HOME PAGE ABOUT US CONTACT US SUBSCRIBE ADVERTISE ARCHIVES
TOP STORIES NATION ECONOMY COMPANIES SHIPPING OPINION PERSPECTIVE LIFE SPORTS MOTORING
SEARCH ENGINE
WWWOur Site
Anchored by Jonathan dela Cruz, Salvador Escudero, Boying Remulla, Teddy Boy Locsin and Alvin Capino
Monday to Friday
8:00pm-10:00pm

ARTICLE SERVICES
  • bookmark this page
  • print this article
  • view archive
  • Unilab to help market
    natural ingredients
     
    By Jennifer A. Ng
    Reporter

    UNITED Laboratories Inc. (Unilab), considered one of the biggest pharmaceutical firms in the country, is keen on helping biotech companies extracting natural ingredients as a source of compounds for medicines market their product.

    Jose Maria Echave, Unilab’s vice president for business development, said the company is encouraging scientists to bring their natural pharmaceutical products for possible development and collaboration in marketing them.

    Echave made the pronouncement at the fourth Philippine Biotechnology Venture Summit held at the Ateneo School of Medicine and Public Health.

    “If you have a very good natural product, we are willing to listen,” said Echave.

    He noted that the trend now in pharmaceuticals is to go biologicals, adding that the Philippines has the edge since the country has a strong natural-ingredients industry.

    “In the pharmaceuticals sector the way to go now is biologicals. The era of blockbuster synthetic drugs is about to end,” said Echave.

    Unilab is also encouraging scientists to use biotechnology to develop vaccines. Currently, a Filipino company, Servac Philippines Corp., is developing an anti-rabies serum from the antibodies produced by horses. Servac hopes to make the vaccine commercially available by the end of the year.

    Another area in which biotechnology can venture into is the development of dengue diagnostic kits. “Anything portable, anything you can bring down to the lowest unit to the community will be very, very useful. It has to be at a good price point, we are looking at P5 [as possible price]. If you can come up with drugs that is at P5, then we can do business,” said Echave partly in Filipino.

    He, however, cautioned scientists that the efficacy of natural ingredients must be backed up by clinical evidence.

    “There are ways by which we can develop our resources but there has to be a good clinical evidence. Hindi puwedeng endorsement lang [Endorsement is not sufficient],” he said.

    Data from the National Integrated Research Program on Medicinal Plants showed the Philippines has over 1,500 identified medicinal plants. Many of these plants have been endorsed by the Department of Health. They include bayabas, bawang, ampalaya, sambong, yerba buena, lagundi, akapulko, pansit-pansitan, tsaang-gubat and niyog-niyogan.

    Pascual Laboratories Inc., the second biggest Filipino pharmaceutical company, has succeeded in marketing phytomedicines (herbal medicines) with anticough medicine from lagundi popularly known as Ascof and a medicine from sambong to help prevent kidney stones, Re-Leaf.

    OTHER STORIES

    2 polls: Pinoys OK lifestyle change, are pro-environment


    Pinoys among the more environment-conscious citizens in the world


    UN honors 7 ‘Champions of the Earth 2008’


    BIR exceeds Q1 target by P2.6B


    ‘Perks reforms to fill revenue gap’


    House to call Yap on P250-B plan


    BSP now eyeing fine-tuning of banks’ deposit reserves


    RWBs to rush pay-hike bids; Loren cites data


    Unilab to help market natural ingredients


    Flour millers slam Customs over ‘rampant’ smuggling


    Oxygen dip imperils milkfish


    AES completes Masinloc takeover


    Pakistan ratifies, signs rights pacts